WuXi AppTec Confirms AGM and Share Class Meeting Results, Governance Changes and Dividend

WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.

WuXi AppTec reported the poll results of its 2025 annual general meeting and the first 2026 class meetings for both A and H shareholders, all held in Shanghai on April 28, 2026. Voting was conducted on-site and online via the Shanghai Stock Exchange systems for A shareholders and on-site for H shareholders, with details of resolutions available in prior meeting documents.

The announcement confirms proper convening and attendance at the meetings, with nearly 2.98 billion issued shares eligible to vote at the AGM. Certain directors, potential award scheme participants and their associates, holding about 16.36% of issued shares, abstained from voting on resolutions related to directors’ remuneration and H share award and trust schemes, ensuring compliance with Hong Kong listing rules and avoiding conflicts of interest.

The company also addressed governance matters including re-election of executive, non-executive and independent non-executive directors, payment of a final dividend and amendments to its Articles of Association. No shareholders, other than those required, abstained or voted against the resolutions, indicating broad shareholder support for the company’s governance framework, incentive schemes and capital return policies.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$150.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

More about WuXi AppTec Co., Ltd. Class H

WuXi AppTec Co., Ltd. is a China-based pharmaceutical and life sciences services company listed in Hong Kong. The group provides contract research, development and manufacturing services for global healthcare customers, with its shares divided into A shares on the Shanghai Stock Exchange and H shares in Hong Kong.

Average Trading Volume: 4,684,003

Technical Sentiment Signal: Buy

Current Market Cap: HK$339.2B

For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.